111 related articles for article (PubMed ID: 31686836)
1. CITED1 contributes to the progression of papillary thyroid carcinoma via the Wnt/β-catenin signaling pathway.
Wang Y; Huang H; Hu F; Li J; Zhang L; Pang H
Onco Targets Ther; 2019; 12():6769-6777. PubMed ID: 31686836
[TBL] [Abstract][Full Text] [Related]
2. CITED1 gene promotes proliferation, migration and invasion in papillary thyroid cancer.
Xia E; Wang Y; Bhandari A; Niu J; Yang F; Yao Z; Wang O
Oncol Lett; 2018 Jul; 16(1):105-112. PubMed ID: 29928391
[TBL] [Abstract][Full Text] [Related]
3. LncRNA SNHG12 promotes the proliferation and metastasis of papillary thyroid carcinoma cells through regulating wnt/β-catenin signaling pathway.
Ding S; Qu W; Jiao Y; Zhang J; Zhang C; Dang S
Cancer Biomark; 2018; 22(2):217-226. PubMed ID: 29630517
[TBL] [Abstract][Full Text] [Related]
4. CITED1 promotes proliferation of papillary thyroid cancer cells via the regulation of p21 and p27.
Li H; Guan H; Guo Y; Liang W; Liu L; He X; Ke W; Cao X; Xiao H; Li Y
Cell Biosci; 2018; 8():57. PubMed ID: 30450190
[TBL] [Abstract][Full Text] [Related]
5. FOXE1 supports the tumor promotion of Gli2 on papillary thyroid carcinoma by the Wnt/β-catenin pathway.
Ma J; Huang X; Li Z; Shen Y; Lai J; Su Q; Zhao J; Xu J
J Cell Physiol; 2019 Aug; 234(10):17739-17748. PubMed ID: 30793770
[TBL] [Abstract][Full Text] [Related]
6. Aberrant promoter methylation in overexpression of CITED1 in papillary thyroid cancer.
Sassa M; Hayashi Y; Watanabe R; Kikumori T; Imai T; Kurebayashi J; Kiuchi T; Murata Y
Thyroid; 2011 May; 21(5):511-7. PubMed ID: 21449767
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of TRIM44 inhibits the proliferation and invasion in papillary thyroid cancer cells through suppressing the Wnt/β-catenin signaling pathway.
Zhou Z; Liu Y; Ma M; Chang L
Biomed Pharmacother; 2017 Dec; 96():98-103. PubMed ID: 28965013
[TBL] [Abstract][Full Text] [Related]
8. LncRNA PTCSC3/miR-574-5p Governs Cell Proliferation and Migration of Papillary Thyroid Carcinoma via Wnt/β-Catenin Signaling.
Wang X; Lu X; Geng Z; Yang G; Shi Y
J Cell Biochem; 2017 Dec; 118(12):4745-4752. PubMed ID: 28513866
[TBL] [Abstract][Full Text] [Related]
9. Preparation and SPECT/CT Imaging of
Li J; Zhang L; Li W; Lei C; Cao Y; Wang Y; Wang Z; Pang H
Onco Targets Ther; 2020; 13():487-496. PubMed ID: 32021292
[TBL] [Abstract][Full Text] [Related]
10. CircRNA circRNA_102171 promotes papillary thyroid cancer progression through modulating CTNNBIP1-dependent activation of β-catenin pathway.
Bi W; Huang J; Nie C; Liu B; He G; Han J; Pang R; Ding Z; Xu J; Zhang J
J Exp Clin Cancer Res; 2018 Nov; 37(1):275. PubMed ID: 30424816
[TBL] [Abstract][Full Text] [Related]
11. Upregulated miR-155 in papillary thyroid carcinoma promotes tumor growth by targeting APC and activating Wnt/β-catenin signaling.
Zhang X; Li M; Zuo K; Li D; Ye M; Ding L; Cai H; Fu D; Fan Y; Lv Z
J Clin Endocrinol Metab; 2013 Aug; 98(8):E1305-13. PubMed ID: 23796566
[TBL] [Abstract][Full Text] [Related]
12. LncRNA ABCC6P1 promotes proliferation and migration of papillary thyroid cancer cells via Wnt/β-catenin signaling pathway.
Guan Y; Li Y; Yang QB; Yu J; Qiao H
Ann Transl Med; 2021 Apr; 9(8):664. PubMed ID: 33987362
[TBL] [Abstract][Full Text] [Related]
13. Circular RNA Pvt1 oncogene (CircPVT1) promotes the progression of papillary thyroid carcinoma by activating the Wnt/β-catenin signaling pathway and modulating the ratio of microRNA-195 (miR-195) to vascular endothelial growth factor A (VEGFA) expression.
Zeng L; Yuan S; Zhou P; Gong J; Kong X; Wu M
Bioengineered; 2021 Dec; 12(2):11795-11810. PubMed ID: 34927541
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of TRIB2 by Wnt/β-catenin activation in BRAF
Wang N; Wen J; Ren W; Wu Y; Deng C
Cancer Chemother Pharmacol; 2021 Jul; 88(1):155-164. PubMed ID: 33860836
[TBL] [Abstract][Full Text] [Related]
15. ETS like-1 protein ELK1-induced lncRNA LINC01638 accelerates the progression of papillary thyroid cancer by regulating Axin2 through Wnt/β-catenin signaling pathway.
Lv P; Xue Y
Bioengineered; 2021 Dec; 12(1):3873-3885. PubMed ID: 34281460
[TBL] [Abstract][Full Text] [Related]
16. FOXN3 suppresses the growth and invasion of papillary thyroid cancer through the inactivation of Wnt/β-catenin pathway.
Zhao C; Mo L; Li C; Han S; Zhao W; Liu L
Mol Cell Endocrinol; 2020 Sep; 515():110925. PubMed ID: 32619584
[TBL] [Abstract][Full Text] [Related]
17. Klotho Inhibits Proliferation in a RET Fusion Model of Papillary Thyroid Cancer by Regulating the Wnt/β-Catenin Pathway.
Wu Q; Jiang L; Wu J; Dong H; Zhao Y
Cancer Manag Res; 2021; 13():4791-4802. PubMed ID: 34168498
[TBL] [Abstract][Full Text] [Related]
18. Roles and signaling pathways of CITED1 in tumors: overview and novel insights.
Chen W; Jiang J; Gao J; Wang G; Wang R; Lv J; Ben J
J Int Med Res; 2024 Jan; 52(1):3000605231220890. PubMed ID: 38190845
[TBL] [Abstract][Full Text] [Related]
19. LncRNA FALEC promotes proliferation, migration, and invasion of PTC cells through regulating Wnt/β-catenin signaling pathway.
Xiao X; Li L; Cui JC; Wang Y
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4361-4367. PubMed ID: 32373973
[TBL] [Abstract][Full Text] [Related]
20. LEM domain containing 1 promotes thyroid cancer cell proliferation and migration by activating the Wnt/β-catenin signaling pathway and epithelial-mesenchymal transition.
Xu M; Lin B; Zheng D; Wen J; Hu W; Li C; Zhang X; Zhang X; Qu J
Oncol Lett; 2021 Jun; 21(6):442. PubMed ID: 33868480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]